BioPharma Pharma & Biopharma Manufacturing
Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.
Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...
May 26, 2021 | News
Cytiva and Prestige Biopharma to accelerate manufacturing COVID-19 vaccines and antibody therapies.
Cytiva and Prestige Biopharma have formed a collaboration to accelerate manufacturing COVID-19 vaccines and antibody therapies. With Cytiva’s cell cu...
May 26, 2021 | News
The Cost of Under- and Over-Coating Zinc
But for manufacturers who provide these zinc-coated products, the cost of zinc has increased substantially over the past few years, emphasizing the need to...
May 26, 2021 | Opinion | By By Chris Burnett
COVAXIN® production volumes ramped up by Bharat Biotech, by additional 200 million
The company plans to produce 200 million doses of COVAXIN® per annum in the good manufacturing practice (GMP) facilities that are already operatio...
May 21, 2021 | News
Basilea awarded CARB-X grant of up to USD 2.7 million
Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has been awarded a grant of up to USD 2.7 million from CARB-X (Combating Antibiotic-Resistan...
May 19, 2021 | News
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will build a €165 million ($200 million USD) h...
May 18, 2021 | News
Cytiva launches sustainability plan - ‘Designing in sustainability’
Cytiva sets out a sustainability plan to positively affect people and the planet, which underpins business resilience in a fast-changing world Performan...
May 13, 2021 | News
Advancing gene therapy by solving challenges in scale-up & manufacturing
Dr. Brophy shares additional insight about how producing viral vectors can be made more efficient, the lessons that can be learned from manufacturing mAbs ...
May 11, 2021 | Influencers
Regulations: managing the balance of risk and rewards
Some companies see regulations and compliance guidelines as hurdles to overcome. Avantor views them as a challenge to be met, with innovation and expertise...
May 11, 2021 | Opinion
Samsung Biologics and TG Therapeutics to enable global manufacturing of ublituximab
Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization and TG Therapeutics (NASDAQ: TGTX), today...
April 26, 2021 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
